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Genealogies for the Mexican-American city of Laredo, Texas, have been assem- 
bled by computer from individual civil and church records of birth, marriage, and 
death. Documentation is available on vital events in the lives of over 300,000 
individuals, about 80% of the city population from 1870-1981. These data were 
collected to determine the degree to which death from cancer is more clustered in 
families than would be expected by chance alone; methods specific to this data 
base have been developed to accomplish this task. A statistically significant excess 
of familial cancer was observed overall when all cancer sites were pooled, but no 
evidence was observed for excess familial risk at single sites except for breast 
cancer and perhaps for ovarian cancer. The excess of breast cancer risk is 
comparable to that observed in other populations. A few site-combinations mani- 
fest excess familial risk, most notably those involving and dominated by breast 
cancer and certain digestive system sites. We do not confirm the degree of 
familiality observed elsewhere for cancers of the lung, colorectum, stomach, or 
other sites in this generally low-risk population. Even where we find evidence of 
excess risk, the degree of excess is small and the number of multiply affected 
families too small to test etiologic models by segregation analysis. The absence of 
excess familial risk does not appear to be due to inadequate numbers of cases, 
since breast cancer is familial with no more occurrences in Laredo than other 
sites. These results differ to some extent from those found in a similar study of 
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Utah Mormons, but it is unclear whether this is because of differences in risk 
patterns or statistical properties of the analytic methods used in the two studies. 
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JNTRODUCTION 
It is said that at least 80% of all cases of cancer are attributable to environmental 
factors and hence could be prevented with proper avoidance of risk factors extrinsic 
to the individual [Doll and Peto, 19811. There are some notable exceptions, cancers 
that appear with elevated frequency in particular families and cancers known to have 
a hereditary basis. Cancers known to be simply inherited include some tumors of 
childhood, such as retinoblastoma, and some Wilms tumors, as well as cancers of 
adult onset, most notably colon cancer associated with familial polyposis, multiple 
neoplasia syndromes, and perhaps some breast cancer. In rare instances, specific 
genes or chromosome regions have been identified in support of the epidemiologic 
evidence that the tumor has a genetic basis requiring variable environmental contri- 
butions [Schimke, 1978; Strong, 1982; Swift, 19821. 
For many other cancers, there exist reports of a modest elevation of familial 
risks in some populations, with relative risks on the order of 2.0 [eg, Anderson, 
1982; King et al, 1984; Lipkin et al, 1980; Schimke, 19781. Some studies showing 
such an excess risk have been based on hospital or clinic ascertainment, allowing a 
possibility that selection bias is responsible for the observed excess. Population-based 
studies have shown familial risk [Jacobsen, 1946; Macklin, 1959; Woolf, 19551, but 
in one of the first population based studies very little concordance was found among 
Danish twins, suggesting that genetic factors were not generally important in cancer 
epidemiology [Harvald and Hauge, 19631. 
In the only whole-population study of familial cancer to date, genealogies for 
the Mormon population of Utah were computerized and linked to death certificates. 
From these genealogies, the genetic relationships between cases of cancer have been 
compared to the relationships that would be expected among randomly chosen age-, 
sex-, and cohort-matched individuals from these same genealogies [Hill, 1980a,b; 
Skolnick et al, 1981; Bishop and Skolnick, 19841. The expectations were derived 
from simulations, using the genealogies as a reference frame. For single cancer sites 
and certain sets of sites, there was an excess of cases among closely related individuals 
compared to chance expectation. 
We report here a study similar in nature to the Utah effort; genealogies from the 
Mexican-American city of Laredo, Texas, have been assembled from church records 
and linked to all death certificates from 1900 to the present [Buchanan et al, 1984; 
Schwartz et al, 19841. We have assessed the degree of familial aggregation of death 
from cancer based on the total death experience of the population, which does not 
require simulation. Mexican-Americans have characteristic cancer patterns, and here 
we investigate whether there are differences in the amount or nature of familial 
aggregation. For comparative purposes, we have tested most of the same cancer site 
pairs reported in the Utah studies. The epidemiology of breast cancer in Laredo, 
including its familiality, has been discussed in detail elsewhere [Buchanan et al, 19851. 
MATERIALS AND METHODS 
The city of Laredo lies on the Rio Grande River at the Texas-Mexico border 
and, with the exception of the Mexican sister city of Nuevo Laredo, is surrounded by 
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arid rangeland for 100 miles in all directions; geographic isolation makes Laredo a 
good sampling unit for epidemiologic study. For much of its history, Laredo was part 
of Mexico and has remained ethnically Mexican-American and predominantly Roman 
Catholic. Records of the births, marriages, and deaths of most Laredoans have been 
maintained by the Church since the founding of the town in 1785. Some 170,000 
baptism, 99,000 marriage, and all 54,000 city death records from Laredo were 
photocopied and computerized, and these records imply the existence of another 
130,000 individuals who have lived, but were not born, in the city and who may have 
died there. The death records extend from the beginning of mandatory registration in 
about 1900 through 1981. The data base includes records on approximately 7 5 8 0 %  
of current residents of the city [Buchanan et al, 19841. 
The effects of the twin city of Nuevo Laredo, across the Rio Grande from 
Laredo, and of the 20% of the population not represented are, we think, small and 
not of a biasing nature. It is not likely that individuals preferentially went across the 
river to die, undocumented, of cancer. While Mexicans do come to the medical 
facility in Laredo on some occasions, our study is based on those represented in the 
genealogies and hence is not affected by deaths of others. Similarly, while the study 
reported here is of the Roman Catholic population of Laredo, there is no reason to 
think that the data are unrepresentative of the general population. 
Causes of death are given in variable number and format, depending on the 
civil record forms in use at any given time. For recent decades, primary and 
contributory causes are differentiated. Deaths were coded according to the specifica- 
tions and format of the ICD-9 [WHO, 19781. We have lists of all of the certifying 
physicians and for recent ones can identify a specialty (if applicable). However, in 
general, the number of signing physicians at any one time has been small (less than 
10 for 1900-1930, less than 30 subsequently). It is not possible to judge their accuracy, 
except that the age patterns and cause distribution are consistent with what we know 
of the expected epidemiology in the area [eg, Badzioch, 19821. This provides at least 
indirect confirmation of the reliability of the records. Autopsy verification has not 
been done to our knowledge. 
Genealogies have been assembled from these 450,000 or so records by a 
complex, interactive-automated software system developed by us [Buchanan et al, 
1984; Schwartz et al, 1984; also available as technical reports from the first author 
(K.M. W.)]. At all stages of the computerization and record-linkage, extensive error 
checking and verification have been done to ensure that the resultant genealogies are 
as error-free as possible. The genealogies represent the population from the late 1800s 
up to about 1980. The linked death records provide an essentially complete mapping 
onto the genealogies of deaths occurring in Laredo during this century; that is, 
virtually all Laredoans in our genealogies who died in the city have their deaths linked 
to the genealogies. The structure of the genealogies is indicated in Tables I and 11, 
which give the distribution of sibship sizes available in the population and the 
distribution of the sizes of the genealogical structures making up the data base. Table 
I shows that there are numerous large sibships in which to observe multiple occur- 
rences of disease should they occur. Table I1 shows that there are a large number of 
sizeable genealogies, providing ample opportunity to observe multiple affected rela- 
tives of probands. 
These genealogical structures include all individuals we could identify who were 
related, by descent or marriage, to any starting individual. All individuals in the data 
124 Weiss et al 
TABLE I. Sibship Size Distribution in Laredo Genealogies 
Size Frequency Size Frequency Size Frequency 
1 51,863 7 1,195 13 54 
2 12,297 8 742 14 16 
3 6,601 9 526 15 16 
4 4,027 10 329 16 8 
5 2,586 11 177 17 3 
6 1,808 12 109 
Total 82,357 
TABLE 11. Disjoint Distribution of Genealogy 
Structure Sizes 
Genealogy structure No. of such Total individuals 
size (unique indiv.) structures involved 
3 28,789 86,367 
4 7,568 30,272 
5 2,972 14,860 
6 3,933 23,598 
7 1,547 10,829 
8 992 1,936 
9 604 5,436 
10 407 4,070 
11-20 1,085 14,735 
21-30 I36 3,289 
31-81 63 2,671 
98,405 1 98,405 
Total 48,097 302,468 
base were used as index cases unless they had been included previously in a genea- 
logical structure; hence in the structures of Table 11, no individual is counted more 
than once (ie, the table gives the distribution of exhaustive, disjoint structure sizes). 
Many of the “families” consist only of a single individual and hidher parents; these 
represent incomplete families, unlinkable data, and families who either immigrated to 
or emigrated from Laredo. This is a sizeable number of incomplete families; on the 
other hand, Table I1 shows that one genealogical structure contains about 100,OOO 
individuals, or about one-third of the city’s residents over the past century. Although 
most of these individuals are related only by a multiplicity of marriage links (ie, have 
no genetic relationship), most members of the genealogical structure will have a 
substantial number of biological relatives in the structure. (One might consider how 
difficult it would be to identify as many connected individuals over a century’s time 
in other places solely from birth and marriage records in a single population.) 
The processes by which the records were linked or by which the assembled 
genealogies are ascertained do not depend on the individual with whom one starts. 
Hence nothing in the analysis depends on the order of identification of probands or 
family members. Because the analysis is restricted to those individuals lineally related 
to each other, the terms family and genealogy will henceforth refer only to nuclear or 
extended sets of lineal relatives but not to whole genealogical structures containing 
affinal relatives as well. 
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We cannot confirm paternity directly in these data, and so we have no way to 
assess the frequency with which incorrectly attributed paternity obscured true family 
connections. However, preliminary results from a study in a nearby community, 
which is virtually the same ethnically, indicate that the rate of exclusions based on 
genetic markers is only a few percent. It should also be noted that such errors will 
diminish rather than augment the apparent evidence for familial susceptibility and that 
most if not all comparative studies in the literature have unconfirmed parentage. 
To assess the epidemiological characteristics of cancer in Laredo, we have used 
the U.S. census of Laredo for every decennial period from 1900 to the present. From 
these and the death records, mortality statistics have been computed to compare to 
those of the U.S. population at large and to find secular trends in cancer mortality. 
To evaluate the familiality of cancer, we have developed our own measure based 
on a complete enumeration of all the person-years lived by members of the genealo- 
gies and the occurrence of cancer death among those same individuals. This represents 
the entire exposure history of the genealogical population. The entire exposure history 
of the Laredo genealogies was tabulated according to sex, age, and period of birth. 
The number of person-years lived by each individual was tabulated and grouped 
according to age in categories 0-14, 15-39, 40-59, and 60+,  chosen because they 
relate to life-stages and can separate early-, middle-, and late-onset disease. To 
account for possible secular trends in occurrence or diagnosis of disease, person- 
years were further tabulated according to sex and to the time period when they 
occurred using the intervals 1870-1899, 1900-1929, 1930-1959, and 1960+, chosen 
largely for about equal length and for convenience and also (in regard to pre- and 
post-1930 periods) roughly to divide the pre- and postantibiotic eras. 
The tabulation thus consists of four age groups, four time periods, and two 
sexes, or a breakdown of the entire Laredo experience into 32 strata. When sexes 
were pooled, there were a total of 16 strata. The numbers of person-years in these 
strata are given in Table 111. The total experience is 1,064,234 male years and 
1,032,734 female years (2,096,968 person-years overall). 
TABLE 111. Distribution of Total Person-Years (pyr) of Experience in the Laredo Data Base* 
Historical time period 
Age and Before 1900 1900- 1929 1930-1959 After 1960 
sex group pers PY r pers PY r pers PY r pers PY 
0- 14 
M 7,563 75,138 16,857 142,709 17,163 155,101 4,691 23,442 
F 7,328 74,417 16,409 142,537 17,092 158,808 4,960 27,876 
M 3,195 42,804 11,328 149,808 16,443 192,691 9,762 82,438 
F 3,245 40,301 11,443 144,374 16,036 175,012 9,908 78,173 
M 729 8,009 3,494 34,672 6,764 74,938 3,057 18,426 
F 569 5,888 3,393 34,836 5,825 67,119 2,201 12,805 
M 149 1,448 943 8,437 3,165 29,127 2,712 25,046 
F 96 775 858 8,034 3,313 35,282 2,675 26,497 
*Note that in each cell the number of persons is given first followed by the number of person-years lived 
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For each cancer site tested, the sex and age and time period when each case 
died were tabulated; that is, all cancer deaths were partitioned into these 32 cells. 
Using the person-years already tabulated and the numbers of deaths, the sex-, age-, 
and time-specific death rates (deaths per person-year) were computed for each cell. 
These are the empirical rates for Laredo, involving a complete enumeration, and they 
form the basis of all comparisons. 
For each site, all cases were ascertained sequentially from the genealogical data 
base and used as probands for a family analysis. All family members of the proband 
were identified, and their person-year exposure history was tabulated, just as was 
done for the total population. Because all cases were probands, if there were n cases, 
the experience of n families (one for each proband) was tabulated. Thus multiplex 
families (with more than one affected individual) will be represented as often as they 
have cases. This is a form of complete ascertainment and yields the correct expected 
values for the probabilities of disease in the tabulated cells under the null hypothesis 
of no familiality, as we show in the Appendix. 
The initial analysis of the patterns of familial cancer was done by tallying the 
first- and second-degree relatives of the probands. We also repeated this analysis, 
with all lineal relatives (the complete genealogy) of each proband taken into account. 
We report here the results of the first analysis only, because the results from the 
extended families were almost identical. This is consistent with theoretical expecta- 
tions and with the findings in Utah [Hill, 1980a,b; Skolnick et al, 19811, where most 
excess risks were found to be concentrated in close relatives. 
TESTS OF SIGNIFICANCE 
The objective of this analysis is to determine whether there is evidence for 
excess cancer risk among relatives of affected individuals compared to risk in the 
population as a whole. Because the probands comprise all cases in the population and 
the genealogies represent the whole population, it was not necessary to select a control 
group. Rather, we determined whether the probability that an individual dies of the 
disease in question while passing through a particular cell is greater if that individual 
is related to an affected proband than if he/she is an average sex- and age-matched 
member of the population. To do this we have computed the exact upper tail 
probability (n) that at least as many as the observed number of deaths would occur 
by chance, with the observed number of entrants into each cell as the number of 
independent observations, and used the population probability of death as the true 
parameter under the null hypothesis of no familiality (see Appendix equation A5). 
As a result, for each of the exposure cells, we compute the probability of death 
derived from the population and the probability of death derived from the relatives. 
This was done using life-table methods for the cell involved; we did not compute 
whole-life risks, because our study spans a century during which risks by age and sex 
changed greatly, and we wanted to be able to look for specific age groups, sex, or 
time periods in which excess risk might be manifest. In practice, only about four cells 
were informative for each sex, namely, those involving older individuals in recent 
decades. There are several reasons for this. First, cancer will occur only rarely in 
younger individuals, and sample sizes are not sufficient to detect excess. Second, the 
actual occurrence of cancer, and the ability to diagnose it, have been low until the 
latter two historic time periods. Finally, the sample sizes in the older age categories 
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are so small, in earlier time periods, that we could not expect to detect risk differences 
for site-specific cancers. Clearly, this data base extends well beyond the time periods 
for which detailed cancer epidemiological statistics can be developed for a single 
small population. 
To determine the probability of observing the series of probabilities for a given 
site, we used the fact that 
-2 log, a 
is asymptotically distributed as a x2 with 2 df, where a is defined as above [Anderson 
and Bancroft, 19521; thus minus twice the sum of the logarithms for the m cells for 
which we compute ?r has a x2 distribution with 2m degrees of freedom. This yields 
an approximate test of the overall significance of the results, approximate because the 




In Table IV we present, by site, the total number of malignant neoplasms 
recorded anywhere on the death certificates, including multiple cancers recorded in 
the same individual. The large number of site-unspecified diagnoses includes cases of 
unknown primary site as well as cases of stated primary site in addition to stated 
metastases or nonspecific/unspecified primary site. These latter deaths were often 
recorded as “carcinomatosis. ” 
In Table V(A) we provide the age and time distributions of all cancer deaths in 
Laredo separately for males and females to show the nature of the available sample. 
Not all of these deaths were mapped onto the genealogies; such mapping depended 
on a person’s having had some life event documented in the city, essentially having 
been a member of the Catholic Church, and, if not born or married in Laredo, having 
had a child born there. The year of death groups are chosen to span U.S. censal years 
TABLE IV. Distribution of Malignant Neoplasms Recorded on 
Death Certificates in Laredo, 1895-1981* 
Site No. of 
(ICD-9 code) cases 
Lip, oral cavity, and pharynx (140-149) 105 
Digestive organs and peritoneum (150-159) 1,258 
Respiratory and intrathoracic organs (160- 165) 523 
Bone, connective tissue, slun, and breast (170-175) 355 
Genitourinary system (179-189) 789 
Unspecified sites (190-199) 1,821 
Lymphatic and hematopoietic tissue (200-208) 167 
Total malignant neoplasms 5,018 
*This table includes all deaths recorded in Laredo; a variable fraction 
of these were linked to individuals represented in the genealogies. 
Unspecified site category includes individuals certified only as 
“carcinomatosis” but does not include individuals for whom a primary 
site was also listed on death certificate. 
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TABLE V(A). Age and Year of Cancer Deaths Registered in Laredo, 1895-1981 
Year Age (Y rs) 
of death < 5  5-14 15-24 25-34 35-44 45-54 55-64 65-74 75+ Total 
Males 
1895-1904 0 0 0 3 4 2 1 6 0 16 
1905-1914 0 0 1 4 3 2 7 7 6 30 
1915-1924 0 1 0 0 5 6 7 8 2 29 
1925-1934 0 1 2 5 I 15 27 20 11 88 
1935-1944 5 0 4 3 10 27 38 32 21 140 
1945-1954 3 2 2 3 6 26 67 51 44 204 
1955-1964 7 2 4 9 12 38 81 105 60 318 
1965-1974 4 5 3 2 12 35 81 135 131 408 
1975-1981 3 2 2 6 8 20 61 95 149 346 
Total 22 13 18 35 67 171 370 459 424 1,579 
Females 
1895-1904 0 0 1 1 6 16 10 6 2 42 
1905-1914 0 1 0 2 13 20 13 9 3 61 
1915-1924 1 1 0 4 9 19 20 9 6 69 
1925-1934 1 1 4 13 32 42 45 22 17 177 
1935-1944 0 4 4 7 21 43 51 33 20 189 
1945-1954 3 3 6 11  32 56 73 73 42 299 
1955-1964 0 1 3 9 26 53 88 94 70 344 
1965-1974 1 2 1 10 24 55 83 135 105 416 
1975-1981 1 2 2 6 14 39 60 100 142 366 
Total 7 15 21 63 183 343 443 481 407 1.963 
TABLE V(B). Age- and Sex-Specific Cancer Death Rates (per 100,000) in Laredo, 1895-1981 
Year Age (yrs) 
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0 0  4 23 25 
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10 5 4 6 35 
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a1975-1981 is a short interval because of unavailability of data at time of study; data for 1981 incomplete. 
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so that rates could be computed. Those rates, shown in Table (V)B, reflect the kinds 
of age and sex patterns observed in the contemporary U.S. population, suggesting 
that the diagnosis of disease is reasonable. The rates also reflect two trends. Age- 
specific cancer rates increase both with age and with time, as has been the national 
experience. Partly this has been due to improvements in the accuracy of diagnosis. 
Generally, however, it relates to the decrease in risk of terminal infectious disease, to 
decreased fertility, and to increased smoking and other exposure to cancer-causing 
agents in the diet and environment [eg, Doll and Peto, 19811. 
The standardized mortality ratios (SMRs) are presented in Table VI for the 
major organ sites for both sexes in 1950 and 1970. Even with 90,000 current 
inhabitants, the population of Laredo is too small to estimate age-, sex-, and site- 
specific cancer rates with precision, so we have used indirect standardization to 
compare cancer death patterns in Laredo to those in the U.S. at large. Further, we 
have averaged the number of deaths (per site and sex) for the decade surrounding 
each census year to reduce the small-sample effect on the SMR. The standard rates 
used were taken from the U.S. white rates given in Vital Statistics of the United 
States, Mortality, Volume B,  for the appropriate years. 
Overall, there was a striking deficit of cancer for the major sites (lung, female 
breast, and colon) and a relative excess of cancer of the cervix and the middle 
digestive system (gallbladder, liver, stomach, and perhaps pancreas), especially in 
females. This is similar to the SMR patterns found among Mexican-Americans in Los 
Angeles and in New Mexico [see Weiss et al, 1984; JNCI Monogr 69, 19821. The 
finding of an excess of cancer deaths at many occult sites suggests that the level of 
TABLE VI. Standardized Mortality Ratios (SMRs) for Malignant Neoplasms in 1950 and 1970 
( U S  as Standard Population)* 
Males Females 
Site 1950 1970 1950 1970 
Buccal cavity and pharynx 1.02 0.79 1.36 0.60 
Stomach 1 .OO 0.88 1.30 1.31 
Colon and rectum 0.24 0.36 0.35 0.38 
Liver I .54 7.81 1.51 8.68 
Gallbladder NA 0.48 NA 1.62 
Pancreas 0.64 1 .OO 1.49 0.99 
Trachea, bronchus and lung 0.90 0.63 1.32 0.86 
Bladder 0.30 0.86 0.74 0.78 
Kidney and O/U urinary organs 0.69 2.04 1.91 0.78 
Breast 0.56 0.98 
Body of uterus, O/U uterus 1.69 0.76 
Cervix uteri 1.12 1.49 
Ovary 0.78 1.82 
Brain 0.34 2.07 0.00 2.00 
Bone and connective tissue 0.45 1.04 1.76 2.29 





0.29 0.46 0.24 0.33 
0.33 0.28 0.71 0.60 
0.76 0.79 0.98 0.91 
*O/U, other or unspecified. Source: Vital Statistics of the United States, B. Mortality, Volume 11, U.S. 
Government Printing Office, for the years indicated; 1950 liver data include gallbladder. 
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diagnosis, at least in later years, is comparable to that found in an average U.S. 
community. 
Although sample sizes are small, the shape of the age-of-onset curves for the 
major cancers (for which there are sufficient data) are very similar to those in other 
populations, indicating that similar factors are at work and, more importantly, that 
the pattern of diagnosis is comparable [Badzioch, 19821 (K.M. Weiss, unpublished 
results). One important trend that we have found is an increase in the death rates of 
postmenopausal breast cancer since about 1940. Death rates of premenopausal breast 
cancer have remained virtually unchanged over the same period and are comparable 
to those in the U.S. population at large [Buchanan et al, 19851. 
Familial Cancer Patterns 
To assess the familiality of cancer, we identified probands for whom there was 
at least one other family member with cancer of the same site. All types of cancer 
represented by a separate ICD-9 code (140-208) were tested. To identify other 
affected relatives, we sampled the probands’ first-degree relatives and grandparents; 
however, inclusion of all lineal relatives did not materially change the result. The 
results of this procedure are presented in Table VII, which includes all instances of a 
multiply affected family for any single site. Only a few sites with multiplex families 
were found, and only in breast cancer did we find a family with more than two 
TABLE VII. Frequency of Site-Specific, Multiply Affected Families in Laredo* 
Cancer site tested Number of Number of multiply 
(ICD-9 code) cases affected families 
Single sites 
Unspecified oropharyngeal (149) 22 1 
Stomach (151) 235 2 
Colon (153) 97 0 
Liver (155) 205 3 
Lung (1  62) 263 3 
Female breast (174) 191 9 
Prostate ( 1  85) 112 1 
Colon/rectum (153/154) 143 1 
Gastrointestinal (1.50-154) 430 8 
Female reproductive system (179- 184) 31 1 5 
Cervixlendornetrium (179-1 82) 234 2 
Urinary system (188-189) 99 I 
Hematopoietic system (159.1, 204-208) 82 0 
CNS (191-192) 36 0 
Lymphatic system (196,201) 23 0 
Site combinations 
Breastlovary (l74/ 183) 263 13 
*Numbers of cases include only those deaths that could be linked to a member of the genealogies. Except 
for one breast cancer family and one family for all gastrointestinal sites, among each of whom there 
were a total of three affected family members, all instances in the table contain only the proband and 
one other family member. All first-degree relatives plus grandparents were included in the family 
members tested. Every cancer site encoded by single ICD-9 codes, from 140 to 208, was tested, but no 
multiply affected families were found except as reported above. The site combinations in the second part 
of the table were tested and reported by Hill in the Utah study (see text). Other site combinations tested, 
with no multiply affected families, include: all cancer in relatives of childhood cancers, digestive system 
and breast (150-151, 155-157, 174), middle digestive system (151-152, 155-157), all female reproductive 
sites plus breast in both sexes and prostate (174-185). 
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affected individuals, a triad of affected individuals in a single family. Familial colon 
cancer, often found elsewhere, has not occurred in Laredo, at least as reflected by 
death certificates. 
There have been many reports of multiple site familial cancer [eg, Anderson, 
1982; King et al, 1984; Schimke, 1978; Strong, 1982; Swift, 19821. We have 
examined familial occurrences for a selection of those grouped sites tested in the Utah 
study, the most comparable other data set showing familial aggregation [Hill, 1980a,b; 
Skolnick et al, 19811. We did find some instances of multiple affection, but most of 
these were due to single sites already reported. Overall, we failed to find support for 
a general or common familial aggregation of cancer. Some sites, however, were 
occasionally familial, but because families contain different numbers, sexes, and ages 
of individuals a tabulation of the fraction of multiplex families does not lead to any 
simple conclusion. 
In both of these tests (single site and multiple site combinations), we enumerated 
the frequency of occurrence of multiply affected lundreds. Because the amount of 
information available on the families varies, as does their size and structure, it is not 
possible to compare this directly to a simple expectation, so more rigorous methods 
are desirable. Thus we tested the pattern of time-, sex-, and age-specific risks as 
described in Materials and Methods. The results of this test for single sites of cancer, 
and for certain groups of organ sites, are presented in Table VIII. Except for sites 
noted in the table, the data are reported for sexes pooled; no additional information 
was contained in the sex-stratified cells. 
Table VIII provides the results of the significance test described above. For 
most sites, there is a substantial probability that the observed excess of familial cases 
occurred by chance alone; that is, there is no evidence in the Laredo data base for 
excess familial risk for most sites. For some sites, however, some or all of the cells 
show only a small probability of such familial clustering by chance alone. Given the 
large number of tests we performed (most of which were not significant), the fact that 
a few sites proved to be significantly clustered in families might be unconvincing 
evidence of familial clustering of risk, even for the implicated sites. For those sites 
for which the overall probability was very small, however, an excess was observed 
in several cells; we therefore conclude that the excess is valid and not a chance 
finding. 
The expected and observed probabilities of death, by sex, age, and cohort for 
each site or site combination shown in Table VIII, do not specify any specific measure 
of excess risk, since there is no single measure that would satisfy all purposes. One 
way to provide a measure of excess risk would be to compute the risk ratio (oij/ei,), 
where oij and eq are the observed and expected risks of death from the designated 
cause for the ijth cell in the table. For example, with regard to breast cancer in women 
who were aged 40-59 during the period since 1960, the expected risk was .023 and 
the observed risk .126, so the risk ratio was 4.48. 
We have tested the site combinations reported by others [eg, Li and Fraumeni, 
1969; Lynch, 1976; Bishop and Skolnick, 1984; Hill, 1980a,b; Skolnick et al, 19811 
as showing most significant, intermediately significant, and no significant clustering 
in families. We find evidence for familial clustering of combined female reproductive 
sites (excluding cervical cancer, which has distinct and generally unrelated epide- 
miology), although this might be due mainly to the clustering of breast cancer. No 
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breast cancer probands. No other combination of sites demonstrated significant 
familial clustering. The Li-Fraumeni familial pattern was not observed in Laredo; it 
is too rare to be expected in a population the size of the Laredo data base. 
To address the question of the degree to which the Laredo genealogies permit 
us to detect excess risk, we present in Table IX the number of relatives available in 
the main informative cells and the 5% critical value (numbers of affected relatives 
required) for the sites summarized in Table VIII. The sites presented there cover the 
general range of values of expected risk and of sample size (number of relatives at 
risk in the cells) for the relatively common cancers. For these critical numbers of 
relatives, Table IX provides the corresponding risk ratios. The critical number of 
affected relatives is that minimum number that would occur by chance less than 5% 
of the time. Because the distributions are discrete binomial, with finite sample sizes, 
the level of significance chosen for these computations is only -5%. The actual 
significance level is always < 5 % . 
Table IX shows that for a wide range of sites and the sample sizes appropriate 
for these data risk ratios on the order of 1.5-3 can be detected at the 5 % significance 
level. This is the general level of excess risk observed in other studies of familial 
cancer. When the observed risk was significantly greater than expected, the observed 
risk ratio, computed directly from Table VIII, was greater than the critical risk ratio 
given in Table IX. 
Figure 1 summarizes the power of the tests used here in a data base the size of 
Laredo. For a range of sample sizes (numbers of at-risk relatives) of 50, 200, and 
l,OOO, generally spanning the Laredo sample sizes, and for a range of risks from 
0.001 to 0.05, Figure 1 presents the power to detect risk ratios up to 10 or more. 
Clearly, for risks on the order of 0.05, the power is adequate to detect even a two- or 
threefold increase. For rarer sites, where risk is on the order of 0.001, adequate 
power to detect small risk ratios requires samples on the order of l,OOO, rarely 
attained in Laredo. 
It is possible that our conclusion that excess familial risk is unusual in Laredo is 
wrong and that there is considerable excess risk that we do not have the statistical 
power to detect. This is not likely to be a serious problem, however, for several 
reasons: 1) Our test includes combined analysis from at least four risk cells, consid- 
erably raising the effective sample sizes. 2) Were familial cancer common, or were it 
to exist for many sites, more of the tests performed in our analysis should have been 
positive even if we could not detect all excess risk that existed. 3) When substantial 
excess risk existed, it was detected in more than one risk cell. 
DISCUSSION 
We are restricted in this study to family events that can be documented from the 
records available to us. Our information differs in certain ways from that of the 
Mormon study. One difference is that our data do not include a registry with 
mandatory case reporting, which was partially available in Utah. Another is that the 
Mormon Church requires of its members that they compile family “group sheets” 
that document relatives in extended nuclear families, whereas we had to document all 
family members directly. We cannot consider events of which we have no direct 
record, of course, but this was true also of the Mormon studies. Mormons have 
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RISK RATIO 
Fig. 1. Power curves for a selection of sample sizes (n), baseline population risks (p), and risk ratios. 
The power curves are drawn with 5 %  critical values corresponding to the values of baseline risk, and 
sample sizes. The computations were performed by evaluating binomial probabilities below the critical 
value, for risks corresponding to the plotted risk ratios. For P = 0.001, small risk ratios result in non- 
monotonic power computations (as a function of n) because of discontinuity of the corresponding 
binomial distributions. 
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individuals will be included on group sheets of Utah Mormons although their deaths 
will not. There have been no major organized immigration patterns into Laredo of 
which we are aware, though clearly there has been steady immigration (including 
family members) from Mexico and some emigration to other parts of the U.S. as well 
as occasionally back to Mexico. There are also immigrants from Europe and other 
parts of the U.S. There is no way to exclude the possibility that important cancer 
patterns are associated with these undocumented events, but there is no reason to 
think that our results are seriously affected by such patterns, and every family study 
must face limited ascertainment of information, since human pedigrees extend beyond 
history in many ways. 
We have adopted a new method to examine familial risk in a whole population 
of genealogies, developing an internal standard for comparing overall risk differ- 
ences, after cohort, sex, and age effects have been taken into account. Our methods 
are variants of stratified standardized incidence-density comparisons. There are sev- 
eral reasons why we feel that the use of the genealogical index (GI), as used in the 
Utah study [eg, Hill, 1980a,b; Skolnick et al, 1981; Bishop and Skolnick, 19841, is 
not ideally suited to our purposes or population sample. First, as Table I shows, the 
Laredo population is an assembly of disjoint genealogies of different structures and 
sizes. The GI between two members of a genealogy is a function of its size and 
structure. Therefore, if the GI between two affected pairs is to be compared to that 
between pairs of matched controls, those controls must be suitably matched in terms 
of the size and structure of their genealogies. This is not generally feasible, yet an 
unrestricted set of controls will yield a different baseline genealogical relationship 
than that applying to the observed cases. Second, when more than one pair of cases 
occurs within a given genealogy, the GI values for each pair are not statistically 
independent. Third, because of the lack of multiply affected genealogies, the GI 
between case pairs in our study would have produced a resultant distribution of GI 
values heavily concentrated at indeterminate values (ie, no known relationship be- 
tween cases). This makes test contrasts inapplicable. 
Finally, the GI might be biased towards close relationships, since close relatives 
are more likely to be present and documented in a population than are more distant 
relatives. Indeed, the genealogical index is a conditional test, comparing the degree 
of relationship among those pairs of caseslcontrols that were linked in the same 
genealogy; the relationship between other pairs is not known, and the fraction of 
unlinkable pairs might be different between cases and controls. The Utah study did 
find closer kinship among case pairs [Skolnick et al, 1981; Bishop and Skolnick, 
1984; Hill, 1980al. 
Some of these problems have been discussed in an analytical context by Chak- 
raborty [1985]. Our method here is a more direct comparison of familial risk, with a 
baseline risk applicable to the entire Laredo population (age/sex/cohort stratified) 
rather than to specific genealogical relationships. The method is also free of the 
inherent distributional and sampling uncertainties associated with simulation as well 
as certain other problems [Chakraborty, 19851. 
It is clear that we do not confirm the degree of familiality that has been reported 
in Utah and in other studies for major cancer sites (colon, lung, stomach, and other 
organ systems) with the single exception of breast cancer. Further, familial excess for 
many site combinations reported by the Utah study does not exist in Laredo, even 
though the large families in Laredo provide ample opportunity for multiple affection 
Familial Cancer in Laredo, Texas 137 
to have occurred. If our results were due simply to low cancer prevalence, a low 
probability that multiple cases will occur in small groups such as families, one might 
expect the same problem in Utah. 
It might be that a difference between Laredo and Utah is related to the low 
levels of exposure Mormons are known to have for many of the important risk factors 
for cancer, leading to their generally low rates of cancer. Although Laredo also has 
lower rates of many major cancers, the exposure differences might be relevant to the 
findings for certain sites. For example, Mormon religious beliefs and practices serve 
to reduce exposure to important risk factors (cigarette smoke, alcohol); they fre- 
quently have large family sizes, which might protect to some extent against female 
reproductive site cancers; and Mormons might also have a protective diet. 
It seems unlikely that the genetic basis for susceptibility in Laredo is different 
from that in the largely northern European population of Utah, since the Mexican- 
American population of Laredo is genetically about 75 % European, although largely 
Spanish, in ancestry [Ferrell et al, 1985; Gottlieb, 1983; Relethford et al, 19831. 
The Mormon study included death and incidence data for some parts of its 
population and study period, and our study has been restricted to deaths alone. Other 
familial studies have also used incidence data. Although more cases should be 
discovered with the former approach, there is no reason why morbidity data should 
demonstrate excess familial risk when mortality data do not except in the sense that 
larger sample sizes have increased statistical power. Most of the tumors typically 
showing familial risk have been lethal, especially prior to the increased availability of 
endoscopic and other early detection methods. Therefore, it seems unlikely that our 
overall result would change with the inclusion of morbidity data. 
It is unlikely that poor ascertainment or diagnosis is responsible for the lack of 
cancer familiality that we have observed. It is possible that immigration and emigra- 
tion are nonrandom with regard to familial susceptibility to cancer, but we have no 
reason to suspect that this has been a systematic factor in Laredo. As is shown in 
Table VI, many cancers of occult or difficult-to-diagnose nature are more common in 
Laredo than elsewhere in the U.S. The fact that breast cancer in Laredo exhibits 
familiality and fertility-related epidemiology comparable to the overall U. S. experi- 
ence [Buchanan et al, 19851 indicates that our findings are artifacts neither of 
diagnosis or classification nor of the way in which the genealogies were assembled. 
We conclude that there have been biases of various sorts in many previous studies 
and/or that there is less familial risk, or at least less expressed familial risk, in Laredo 
than typically exists in white populations. 
Although we found a significant excess of cancer in relatives for all sites 
combined, the amount (excess or relative) of the increase was not great. This should 
underline the distinction between a significant excess and an important excess. The 
importance of an excess is to be found in the numerical increase in risk or perhaps in 
biological considerations such as the age at onset. Younger ages of onset, for example, 
may have a greater impact at both population and individual levels than a numerically 
comparable increase of cases at older ages. 
Overall, Mexican-Americans currently have slightly less cancer than the U . S . 
average [Weiss et al, 19801. However, this might be changing; rates at some of the 
common sites are increasing in Mexican-American populations and for some sites, 
such as colon, breast, and lung, might be converging with the U.S. overall rates 
[Buchanan et al, 1985; MacDonald and Heinze, 19781. As this trend continues, there 
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may be an unmasking of familial predisposition not previously expressed. For many 
cancers, familiality might be due to shared environmental exposures; this is something 
that is difficult but important to determine. 
We had originally expected to identify high-risk families in the population with 
the use of nonparametric tests for excess risk [Chakraborty et al, 1980, 1984; Weiss 
et al, 1980; Smouse et al, 19821 and then to perform a large-scale segregation analysis 
on the entire set of extended genealogies so identified. It is now obvious from both 
our results and those of the Utah study that the delayed-onset, low-probability 
expression of most cancers precludes the frequent occurrence of many cases in single 
genealogies [Weiss, 19851. Although it has been done successfully in some samples 
of families for breast cancer [Williams and Anderson, 1984; Go et al, 1983; King et 
al, 19831, and for colon and a few other cancers, we probably will not learn much 
about heritable genetic risk factors for most cancers from segregation analysis. 
Familial cancer is apparently not an important public health problem, but even 
on a population basis it might be important to intensify efforts to identify familial 
susceptibility to cancer precursor states. These can be much more prevalent than 
cancer itself, which develops only in a subset of the vulnerable individuals. When 
such precursors are genetic, their identification would lead to a higher detectability of 
the genes involved as well as provide opportunities for timely intervention [Weiss, 
19851. Also, an effective use of research resources should include the identification 
of those relatively rare families who do in fact manifest greatly elevated cancer 
susceptibility. 
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APPENDIX 
The purpose of this appendix is to describe the methods by which cancer 
mortality was tabulated and contrasted for the population as a whole and for family 
members of affected probands. 
Obtaining the Observed and Expected Death Risks 
All person-years of experience for all individuals in the genealogical data base 
were tabulated. The tabulation was divided into classes according to sex (s: 1 = male, 
2 = female, 3 = both), to age (a: 1 = 0-14, 2 = 15-39, 3 = 40-59, 4 = 60+), 
and to chronological time (c: 1 6 1899, 2 = 1900-1929, 3 = 1930-1959, 
4 = 1960+). In the analysis, we have typically used only sexes-combined or one 
sex, but it is possible to use both; the use of all three sex categories would not be 
correct, of course, since the strata are not disjoint. For all individuals (i: 1-302,468) 
in the data base, we tabulated Yi(a,c,s) as the number of years the individual i spent 
while age a, in the appropriate sex and year category. For example, a male born in 
1910 who lives to be age 48 contributes person-years as follows: 
Yi(1,2,1) = 15 
Yi(2,3,1) = 21 
Yi(3,3,1) = 9. 
Yi(2,2,1) = 4 
In the first category, he reaches age 15 in the year 1925. He spends 4 years aged 15- 
39 still in the historical period 1925-1929, and 21 years still aged 15-39 in the 
historical period 1930-1959. He spends his final 9 years of life, from age 40 to 48 
(inclusive), in the historical period 1930- 1959. 
For the whole data base, we tabulate values of Yi(a,c,s) as 
for each category, summed over all individuals. Each individual who enters a cell 
contributes one “person” to the number of individuals who entered the cell, that is, 
increments a person-counter P(a,c,s). Each death is recorded for a cell in a death 
counter D(a,c,s,j), where j is the cause code for the disease causing death. For 
example, our hypothetical individual added one person to the counters P( 1,2, l ) ,  
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P(2,2,1), P(2,3,1), and P(3,3,1). If he died of cause j ,  he contributed 1 to the counter 
D(3,3, l j ) .  The mortality density in each cell is given by 
R(a,c,s,j) = D(a,c,s,j)/Y.(a,c,s). ('42) 
The mean years lived in each cell, by members of the entire population, is 
determined by 
- 
Y(a,c,s) = Y.(a,c,s)/P(a,c,s), (A31 
and now we can compute the probability that a person who entered the cell survived 
the cell (with respect to the disease in question). We do this by assuming that each 
individual who enters a cell is exposed to a constant mortality density R(a,c,s,j) for 
that cell, as given by eq A2. The probability of surviving V (a,c,s) years at that risk 
is given by the standard formula 
These values are all tabulated initially for the whole population and for each 
specific disease category (eg, cancer site). Then, using similar tabulation methods, 
we compute the analogous values (which we can symbolize by adding a prime to the 
variable name) for those who are relatives of each proband. Hence the totals are now 
summed over all relatives of cases rather than over all N members of the data base. 
Resulting from this are a set of probabilities, S(a,c,sj) and S'(a,c,s,j), and a 
pair of mortality rates, R(a,c,sj) and R'(a,c,s,j). In most cells, however, the rumbers 
are too small and the distributions too sparse to make useful comparisons of the rates 
themselves. To determine the probability, n(a,c,s,j), that we would observe at least 
as many deaths as we have observed, we computed the size of the upper-tail proba- 
bility of a binomial distribution with P', D', and S as parameters. Suppressing the 
series of variables (a,c,sj), this is 
This provides a test of the significance of the observations in each cell, and to obtain 
an approximate overall significance test we use the fact that 
TQ) = -2 CCC ln[a(a,c,sj)] 
a c s  
is distributed as x2 with 2m degrees of freedom, where m is the number of cells 
evaluated [Anderson and Eancroft, 19521. This is the method by which the analysis 
of familiality was computed. Separate runs were made for first- and second-degree 
relatives of the probands, and for all lineal relatives. 
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Tabulation of Multiply Affected Families When There Is Complete 
Ascertainment 
In assessing familial risk in this study, all affected cases were used as probands, 
and the rates of disease in their relatives, divided into 32 risk classes, were compared 
to those in the entire population. This practice differs from most studies in that: 1) 
the probands represent 100% of the cases in the population and 2) every affected 
family member will also be a proband. Thus, many family members' exposure and 
disease experience will be counted more than once (each time a member of the family 
is used as a proband). Here we show that this is a valid way to assess family risk in 
our sampling frame and that it leads to an unbiased estimate of the population risk 
under the null hypothesis of no familial aggregation of disease. 
Families of size n with uniform risk p to each member. Let the data consist 
of a series of families, all of the same size, n, in which the risk of disease is the same, 
p, to each member. If there is no excess familial risk, then the number of affected 
individuals in any family, r (r = 0, 1 . . . n) will be a binomial function of the risk, 
p, and family size, n. If there are N cases in a total population of size T, then p = 
NIT, and the probability that a family of size n has r affected is simply the correspond- 
ing term from a binomial distribution: 
Prob. (r affected I n,p) = (A71 
Because each of the affected individuals will be a proband, this family will be 
ascertained r times. The observed fraction of nonproband members of this family 
who are affected by disease is (r - l)/(n - 1). Hence the weighted total count of 
affected relatives in families consisting of r - 1 affecteds (not including proband) is 
In the whole population of families, then, the estimate of p will be given by the 
weighted average of all possible famiIies of size n (families with n - 1 relatives). 
The expected value of this estimate, E@), is given by 
where the denominator is the sum of all probabilities for families having at least one 
affected individual. The denominator is recognizably equal to the expected value of a 
binomial distribution, np. Equation A9 can be simplified in the following way: 
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= p(p + qp-2 )  = p. 
That is, the expected probability that a relative of a proband is affected, if there is no 
excess familial association of risk, is the population risk, p. This proves that if p and 
n are constant then it is correct to include each family as often as there are cases 
within it. 
A mixture of family sizes. In reality, we have a mixture of family sizes. Let 
nl ,  n2 . . . nN be the family sizes (including proband) for the N cases. The derivation 
above implies that 
E(ri - 1) = (ni - l)p for i = 1 ,  2 . . . N, (A1 1) 
so that a pooled estimate of p is 
N N 
which has expectation 
C (ni - 1) C (ni - 1) 
I =  1 i =  1 
since the family sizes, ni's, are all fixed. 
Mixture of risk levels. In our data, we subdivided the population into 32 
categories, within each of which risk was assumed to be approximately constant. 
These categories involved age, sex, and birth cohort subdivisions of the data. Since 
all relatives within a category have the same risk level (Pk, k = 1, 2 . . . 32), and the 
only varying element over which pooling is done is the number of relatives in the kth 
risk category, the above argument on the mixture of family sizes shows that Pk'S are 
estimated without bias. 
The unbiased nature of the estimated risks and the appropriateness of the test 
criterion used in the text were also checked by means of 100 random trials, for each 
of which 250 random probands and their available relatives were selected; patterns of 
death from cancer in the relatives were shown to be comparable to those expected in 
the population as a whole. 
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